Literature DB >> 23623341

Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients.

Aderville Cabassi1, Jacques de Champlain, Umberto Maggiore, Elisabetta Parenti, Pietro Coghi, Vanni Vicini, Stefano Tedeschi, Elena Cremaschi, Simone Binno, Rossana Rocco, Salvatore Bonali, Michele Bianconcini, Clelia Guerra, Giuseppina Folesani, Alberto Montanari, Giuseppe Regolisti, Enrico Fiaccadori.   

Abstract

BACKGROUND: An accurate prognosis prediction represents a key element in chronic heart failure (CHF) management. Seattle Heart Failure Model (SHFM) prognostic power, a validated risk score for predicting mortality in CHF, is improved by adding B-type natriuretic peptide (BNP). We evaluated in a prospective study the incremental value of several biomarkers, linked to different biological domains, on death risk prediction of BNP-added SHFM.
METHODS: Troponin I (cTnI), norepinephrine, plasma renin activity, aldosterone, high sensitivity-C reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), interleukin 2 soluble receptor, leptin, prealbumin, free malondialdehyde, and 15-F2t-isoprostane were measured in plasma from 142 consecutive ambulatory, non-diabetic stable CHF (mean NYHA-class 2.6) patients (mean age 75±8years). Calibration, discrimination, and risk reclassification of BNP-added SHFM were evaluated after individual biomarker addition.
RESULTS: Individual addition of biomarkers to BNP-added SHFM did not improve death prediction, except for prealbumin (HR 0.49 CI: (0.31-0.76) p=0.002) and cTnI (HR 2.03 CI: (1.20-3.45) p=0.009). In fact, with respect to BNP-added SHFM (Harrell's C-statistic 0.702), prealbumin emerged as a stronger predictor of death showing the highest improvement in model discrimination (+0.021, p=0.033) and only a trend was observed for cTn I (+0.023, p=0.063). These biomarkers showed also the best reclassification statistic (Integrated Discrimination Improvement-IDI) at 1-year (IDI: cTnI, p=0.002; prealbumin, p=0.020), 2-years (IDI: cTnI, p=0.018; prealbumin: p=0.006) and 3-years of follow-up (IDI: cTnI p=0.024; prealbumin: p=0.012).
CONCLUSIONS: Individual addition of prealbumin allows a more accurate prediction of mortality of BNP enriched SHFM in ambulatory elderly CHF suggesting its potential use in identifying those at high-risk that need nutritional surveillance.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Biomarker; Elderly; Heart failure; Mortality

Mesh:

Substances:

Year:  2013        PMID: 23623341     DOI: 10.1016/j.ijcard.2013.04.039

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  14 in total

Review 1.  Redefining biomarkers in heart failure.

Authors:  Michele Correale; Ilenia Monaco; Natale Daniele Brunetti; Matteo Di Biase; Marco Metra; Savina Nodari; Javed Butler; Mihi Gheorghiade
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

2.  The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure.

Authors:  Wioletta Szczurek-Wasilewicz; Michał Skrzypek; Ewa Romuk; Mariusz Gąsior; Bożena Szyguła-Jurkiewicz
Journal:  J Clin Med       Date:  2022-05-04       Impact factor: 4.964

Review 3.  Multidimensional Approach of Heart Failure Diagnosis and Prognostication Utilizing Cardiac Imaging with Biomarkers.

Authors:  In-Cheol Kim; Byung-Su Yoo
Journal:  Diagnostics (Basel)       Date:  2022-06-01

4.  Is cardiopulmonary exercise testing essential to indicate ventricular assist device implantation in patients with INTERMACS profile 4-7?

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Daisuke Nitta; Osamu Kinoshita; Kan Nawata; Minoru Ono
Journal:  J Artif Organs       Date:  2016-03-18       Impact factor: 1.731

5.  From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure.

Authors:  Omar F AbouEzzeddine; Benjamin French; Sultan A Mirzoyev; Allan S Jaffe; Wayne C Levy; James C Fang; Nancy K Sweitzer; Thomas P Cappola; Margaret M Redfield
Journal:  J Heart Lung Transplant       Date:  2016-01-15       Impact factor: 10.247

6.  Using EHRs and Machine Learning for Heart Failure Survival Analysis.

Authors:  Maryam Panahiazar; Vahid Taslimitehrani; Naveen Pereira; Jyotishman Pathak
Journal:  Stud Health Technol Inform       Date:  2015

7.  Serum albumin and prealbumin predict the poor outcome of traumatic brain injury.

Authors:  Du Chen; Long Bao; Shi-qi Lu; Feng Xu
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

8.  Association of Serum Prealbumin with Angiographic Severity in Patients with Acute Coronary Syndrome.

Authors:  Chenglong Zhang; Pei Liu; Ke Xia; Han Fang; Minna Jiang; Qiying Xie; Zaixin Yu; Tianlun Yang
Journal:  Med Sci Monit       Date:  2017-08-21

Review 9.  Prognostic scales in advanced heart failure.

Authors:  Wioletta Szczurek; Bożena Szyguła-Jurkiewicz; Łukasz Siedlecki; Mariusz Gąsior
Journal:  Kardiochir Torakochirurgia Pol       Date:  2018-09-24

10.  Myeloperoxidase-Related Chlorination Activity Is Positively Associated with Circulating Ceruloplasmin in Chronic Heart Failure Patients: Relationship with Neurohormonal, Inflammatory, and Nutritional Parameters.

Authors:  Aderville Cabassi; Simone Maurizio Binno; Stefano Tedeschi; Gallia Graiani; Cinzia Galizia; Michele Bianconcini; Pietro Coghi; Federica Fellini; Livia Ruffini; Paolo Govoni; Massimo Piepoli; Stefano Perlini; Giuseppe Regolisti; Enrico Fiaccadori
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.